X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs MERCK LTD - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD MERCK LTD STRIDES SHASUN LTD/
MERCK LTD
 
P/E (TTM) x 13.5 33.8 40.0% View Chart
P/BV x 1.6 3.8 41.4% View Chart
Dividend Yield % 0.6 0.7 84.6%  

Financials

 STRIDES SHASUN LTD   MERCK LTD
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
MERCK LTD
Dec-16
STRIDES SHASUN LTD/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1,2751,060 120.3%   
Low Rs918623 147.4%   
Sales per share (Unadj.) Rs389.6632.4 61.6%  
Earnings per share (Unadj.) Rs28.045.7 61.2%  
Cash flow per share (Unadj.) Rs48.962.3 78.5%  
Dividends per share (Unadj.) Rs4.5011.00 40.9%  
Dividend yield (eoy) %0.41.3 31.4%  
Book value per share (Unadj.) Rs303.1388.8 78.0%  
Shares outstanding (eoy) m89.4216.60 538.7%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.81.3 211.5%   
Avg P/E ratio x39.218.4 213.0%  
P/CF ratio (eoy) x22.413.5 166.0%  
Price / Book Value ratio x3.62.2 167.1%  
Dividend payout %16.124.1 66.9%   
Avg Mkt Cap Rs m98,03613,969 701.8%   
No. of employees `0005.81.6 366.4%   
Total wages/salary Rs m5,8811,487 395.6%   
Avg. sales/employee Rs Th6,005.96,631.9 90.6%   
Avg. wages/employee Rs Th1,014.0939.2 108.0%   
Avg. net profit/employee Rs Th431.2479.4 89.9%   
INCOME DATA
Net Sales Rs m34,83410,498 331.8%  
Other income Rs m1,686242 695.5%   
Total revenues Rs m36,52010,741 340.0%   
Gross profit Rs m6,4281,135 566.2%  
Depreciation Rs m1,872276 679.3%   
Interest Rs m2,2690-   
Profit before tax Rs m3,9731,102 360.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470343 136.9%   
Profit after tax Rs m2,501759 329.5%  
Gross profit margin %18.510.8 170.6%  
Effective tax rate %11.831.1 38.0%   
Net profit margin %7.27.2 99.3%  
BALANCE SHEET DATA
Current assets Rs m38,1656,410 595.4%   
Current liabilities Rs m30,4028,828 344.4%   
Net working cap to sales %22.3-23.0 -96.7%  
Current ratio x1.30.7 172.9%  
Inventory Days Days7758 134.1%  
Debtors Days Days10438 272.2%  
Net fixed assets Rs m37,6391,406 2,676.3%   
Share capital Rs m894166 538.7%   
"Free" reserves Rs m26,2106,286 417.0%   
Net worth Rs m27,1056,455 419.9%   
Long term debt Rs m16,3770-   
Total assets Rs m81,1688,828 919.4%  
Interest coverage x2.8NM-  
Debt to equity ratio x0.60-  
Sales to assets ratio x0.41.2 36.1%   
Return on assets %5.98.6 68.4%  
Return on equity %9.211.8 78.5%  
Return on capital %12.117.1 70.6%  
Exports to sales %08.3 0.0%   
Imports to sales %021.0 0.0%   
Exports (fob) Rs mNA869 0.0%   
Imports (cif) Rs mNA2,209 0.0%   
Fx inflow Rs m13,465959 1,404.4%   
Fx outflow Rs m4,0762,612 156.0%   
Net fx Rs m9,389-1,653 -568.0%   
CASH FLOW
From Operations Rs m2,8811,070 269.2%  
From Investments Rs m-7,051-750 940.5%  
From Financial Activity Rs m3,382-150 -2,257.8%  
Net Cashflow Rs m-788171 -460.8%  

Share Holding

Indian Promoters % 27.7 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 37.8 18.2 207.7%  
FIIs % 8.6 1.0 860.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 29.1 89.0%  
Shareholders   56,241 28,591 196.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   DIVIS LABORATORIES  WOCKHARDT LTD.  VENUS REMEDIES  PLETHICO PHARMA  GLENMARK PHARMA  

Compare STRIDES SHASUN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Firm; IT Stocks Gain(09:30 am)

Asian stocks were relatively subdued in the early trade today, with most regional indices hovering around the flat line following the softer lead stateside.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Feb 21, 2018 11:17 AM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS